The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Hereditary Angioedema: A Broad Review for Clinicians
Abstract
Hereditary angioedema (HAE) is an autosomal dominant disease that afflicts 1 in 10,000 to 1 in 150,000 persons; HAE has been reported in all races, and no sex predominance has been found. It manifests as recurrent attacks of intense, massive, localized edema without concomitant pruritus, often resulting from one of several known triggers. However, attacks can occur in the absence of any identifiable initiating event. Historically, 2 types of HAE have been described. However, a variant, possibly X-linked, inherited angioedema has recently been described, and tentatively it has been named "type 3" HAE. Signs and symptoms are identical in all types of HAE. Skin and visceral organs may be involved by the typically massive local edema. The most commonly involved viscera are the respiratory and gastrointestinal systems. Involvement of the upper airways can result in severe life-threatening symptoms, including the risk of asphyxiation, unless appropriate interventions are taken. Quantitative and functional analyses of C1 esterase inhibitor and complement components C4 and C1q should be performed when HAE is suspected. Acute exacerbations of the disease should be treated with intravenous purified C1 esterase inhibitor concentrate, where available. Intravenous administration of fresh frozen plasma is also useful in acute HAE; however, it occasionally exacerbates symptoms. Corticosteroids, antihistamines, and epinephrine can be useful adjuncts but typically are not efficacious in aborting acute attacks. Prophylactic management involves long-term use of attenuated androgens or antifibrinolytic agents. Clinicians should keep this disorder in their differential diagnosis of unexplained, episodic cutaneous angioedema or abdominal pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biochemical abnormality in hereditary angioneurotic edema
Donaldson, V. H., & Evans, R. R. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90162-1 · Cited by 968
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910
Plasma bradykinin in angio-oedema
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706
Hereditary Angioedema: the Clinical Syndrome and Its Management
FRANK, M. M., GELFAND, J. A., & ATKINSON, J. P. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-5-580 · Cited by 615
AGOSTONI, A., & CICARDI, M. (1992) · Medicine · doi:10.1097/00005792-199207000-00003 · Cited by 610
Treatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities
Gelfand, J. A., Sherins, R. J., Alling, D. W., & Frank, M. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612232952602 · Cited by 607
Colman, R. W., & Schmaier, A. H. (1997) · Blood · doi:10.1182/blood.v90.10.3819 · Cited by 581
Hereditary angioedema with normal C1-inhibitor activity in women
Bork, K., Barnstedt, S.-E., Koch, P., & Traupe, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02483-1 · Cited by 557
HEREDITARY ANGIO-NEUROTIC ŒDEMA
OSLER, W. (1888) · The American Journal of the Medical Sciences · doi:10.1097/00000441-188804000-00004 · Cited by 509
Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition
Slater, E. E. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410070095035 · Cited by 370
Cited by
Zuraw, B. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0803977 · Cited by 693
The diagnosis and management of acute and chronic urticaria: 2014 update
Bernstein, J. A., Lang, D. M., Khan, D. A., Craig, T., Dreyfus, D., Hsieh, F., Sheikh, J., Weldon, D., Zuraw, B., Bernstein, D. I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.036 · Cited by 682
Agostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
Cicardi, M., Banerji, A., Bracho, F., Malbrán, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906393 · Cited by 564
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo
Oschatz, C., Maas, C., Lecher, B., Jansen, T., Björkqvist, J., Tradler, T., Sedlmeier, R., Burfeind, P., Cichon, S., Hammerschmidt, S., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.008 · Cited by 273
Metadata
- Authors
- Nzeako, U. C.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2001-11-12
- Volume
- 161
- Issue
- 20
- Pages
- 2417
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1981415884
- Cited by
- 336
- References
- 52
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.